As of 2026-03-20, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 10.13 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-03-13 | -20.58 |
| 2026-03-12 | -20.70 |
| 2026-03-11 | -21.12 |
| 2026-03-10 | -22.02 |
| 2026-03-09 | -21.59 |
| 2026-03-06 | -22.12 |
| 2026-03-05 | -21.89 |
| 2026-03-04 | -22.73 |
| 2026-03-03 | -22.38 |
| 2026-03-02 | -23.05 |
| 2026-02-27 | -22.58 |
| 2026-02-26 | -22.77 |
| 2026-02-25 | -22.40 |
| 2026-02-24 | -22.58 |
| 2026-02-23 | -22.87 |
| 2026-02-20 | -23.68 |
| 2026-02-19 | -22.67 |
| 2026-02-18 | -22.62 |
| 2026-02-17 | -22.83 |
| 2026-02-13 | -23.27 |
| 2026-02-12 | -22.42 |
| 2026-02-11 | -23.31 |
| 2026-02-10 | -23.48 |
| 2026-02-09 | -23.48 |
| 2026-02-06 | -23.23 |
| 2026-02-05 | -23.40 |
| 2026-02-04 | -24.35 |
| 2026-02-03 | -24.85 |
| 2026-02-02 | -22.24 |
| 2026-01-30 | -22.81 |
| 2026-01-29 | -23.01 |
| 2026-01-28 | -23.80 |
| 2026-01-27 | -24.94 |
| 2026-01-26 | -23.90 |
| 2026-01-23 | -25.04 |
| 2026-01-22 | -25.28 |
| 2026-01-21 | -25.34 |
| 2026-01-20 | -25.28 |
| 2026-01-19 | -24.31 |
| 2026-01-16 | -24.81 |
| 2026-01-15 | -25.14 |
| 2026-01-14 | -23.72 |
| 2026-01-13 | -23.44 |
| 2026-01-12 | -22.99 |
| 2026-01-09 | -22.83 |
| 2026-01-08 | -24.10 |
| 2026-01-07 | -20.72 |
| 2026-01-06 | -20.98 |
| 2026-01-05 | -21.67 |
| 2026-01-02 | -21.21 |